Insider Trading February 11, 2026

Director Kendall E. Stork Sells 3,000 Pathward Financial Shares in $282,450 Transaction

Sale comes as Pathward shares trade near a 52-week high amid mixed quarterly results and active buybacks by management

By Nina Shah CASH
Director Kendall E. Stork Sells 3,000 Pathward Financial Shares in $282,450 Transaction
CASH

Pathward Financial Inc. director Kendall E. Stork sold 3,000 shares on February 9, 2026, at a weighted average price of $94.15 for a total of $282,450. The trade takes place while Pathward stock trades close to its 52-week high and after a quarter that delivered stronger-than-expected EPS but weaker-than-expected revenue. Management share repurchases and a solid corporate health score contrast with the director's sale.

Key Points

  • Director Kendall E. Stork sold 3,000 Pathward Financial shares on February 9, 2026, for $282,450 at a weighted average price of $94.15.
  • Pathward trades near its 52-week high of $95.10, up over 25% in the past six months; market cap is $2.01 billion with a P/E of 11.22, and InvestingPro finds the stock fairly valued relative to growth potential.
  • Management has been actively repurchasing shares while Pathward maintains a "GREAT" financial health score and has paid dividends for 32 consecutive years (current yield 0.22%).

Director Kendall E. Stork disposed of 3,000 shares of Pathward Financial Inc. (NASDAQ: CASH) on February 9, 2026. The shares were transacted at a weighted average price of $94.15, with individual sale prices ranging from $93.88 to $94.31, producing a total transaction value of $282,450.

The sale occurred as Pathward's stock was trading near its 52-week high of $95.10. The shares have advanced more than 25% over the past six months. At the reported valuation, the company carries a market capitalization of $2.01 billion and a price-to-earnings ratio of 11.22. Analysis from InvestingPro cited in company data characterizes the stock as appearing fairly valued relative to its growth potential.

Following the disposition, Stork's direct ownership in Pathward stands at 7,850 shares. In addition, he indirectly holds 2,153 shares that are held in trust. The director's sale is set against a backdrop of active capital allocation by company leadership: InvestingPro data shows management has been buying back shares aggressively.

Corporate health metrics available through the same data set indicate that Pathward maintains an overall "GREAT" financial health score. The firm has also preserved a long record of shareholder distributions, paying dividends for 32 consecutive years. The current dividend yield is modest at 0.22%.

For investors seeking deeper analysis, Pathward is listed among more than 1,400 U.S. equities covered by comprehensive Pro Research Reports that synthesize financial data into actionable research.


Recent financial results from Pathward's first quarter of fiscal year 2026 reflected a mixed performance. The company reported earnings per share of $1.57, beating the consensus estimate of $1.38 and representing a positive surprise of 13.77% in EPS. Revenue, however, fell short of expectations, coming in at $173.1 million versus the anticipated $185.8 million, a shortfall of 6.84%.

Despite the divergence between profit and top-line results, the company's stock exhibited resilience in the market in the period surrounding these disclosures.


Observed together, the insider sale, ongoing management repurchases, stable long-term dividend history, and mixed quarterly results form the immediate data points available to shareholders and market watchers. No additional forward-looking claims or causal inferences are made beyond the reported facts.

Risks

  • Director sale may signal personal liquidity needs or portfolio rebalancing rather than company outlook - impacts investor sentiment in banking and financials sectors.
  • Revenue missed analysts' expectations in Q1 FY2026 (reported $173.1 million vs expected $185.8 million), introducing top-line uncertainty for performance-sensitive market participants.
  • Mixed earnings signals - EPS beat ($1.57 vs $1.38) alongside a revenue shortfall - could increase volatility in Pathward shares and affect investor confidence in regional financial and specialty finance stocks.

More from Insider Trading

Clean Harbors Director Executes $204,802 Sale as Company Reports Strong Q4 and Pushes M&A Agenda Feb 21, 2026 Clean Harbors Executive Disposes Nearly $1.0M in Stock as Company Posts Strong Q4 Feb 21, 2026 Clean Harbors CFO Disposes $784K in Shares as Company Reports Strong Quarter and Pursues Acquisition Feb 21, 2026 Travelers Executive Vice President Records $1.74 Million Share Sale as Company Posts Strong Quarter Feb 21, 2026 Genasys Director Buys $50,404 of Stock; Company Reports Mixed Q1 Results Feb 21, 2026